Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.68 USD | +3.37% | -0.54% | -31.21% |
Apr. 09 | Harvard Bioscience Reducing Headcount | MT |
Apr. 09 | Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth | CI |
Financials (USD)
Sales 2024 * | 114M | Sales 2025 * | 126M | Capitalization | 155M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 3M | EV / Sales 2024 * | 1.36 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
-712
x | P/E ratio 2025 * |
47.5
x | Employees | 404 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.72% |
Latest transcript on Harvard Bioscience, Inc.
1 day | -3.52% | ||
1 week | -10.33% | ||
Current month | -16.04% | ||
1 month | -13.80% | ||
3 months | -22.78% | ||
6 months | -17.40% | ||
Current year | -33.46% |
Managers | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Jennifer Cote
DFI | Director of Finance/CFO | 52 | 22-04-30 |
David Balcom
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Alan Edrick
BRD | Director/Board Member | 56 | 19-09-02 |
Bertrand Loy
BRD | Director/Board Member | 58 | 14-11-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 4 M€ | -5.15% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.22% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.68 | +3.37% | 1 892 |
24-04-25 | 3.56 | -3.52% | 65,306 |
24-04-24 | 3.69 | -0.81% | 63,556 |
24-04-23 | 3.72 | +0.54% | 92,096 |
24-04-22 | 3.7 | 0.00% | 90,516 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.46% | 155M | |
+7.71% | 218B | |
+6.25% | 182B | |
+10.60% | 132B | |
+26.73% | 108B | |
-0.30% | 62.51B | |
+15.42% | 52.98B | |
-1.89% | 47.59B | |
-1.91% | 39.96B | |
+11.16% | 39.22B |
- Stock Market
- Equities
- HBIO Stock